A method to sequence and quantify DNA integration for monitoring outcome in gene therapy-Reference-Cited by-同舟云学术

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy

Published:2011-03-16 Issue:11 Volume:39 Page:e72-e72
ISSN:1362-4962
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Brady Troy,Roth Shoshannah L.,Malani Nirav,Wang Gary P.,Berry Charles C.,Leboulch Philippe,Hacein-Bey-Abina Salima,Cavazzana-Calvo Marina,Papapetrou Eirini P.,Sadelain Michel,Savilahti Harri,Bushman Frederic D.

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/39/11/e72/16775249/gkr140.pdf

Reference46 articles.

1. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease;Cavazzana-Calvo;Science,2000

2. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy;Hacein-Bey-Abina;N. Engl. J. Med.,2002

3. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1;Hacein-Bey-Abina;J. Clin. Invest.,2008

4. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning;Aiuti;Science,2002

5. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1;Ott;Nat. Med.,2006

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tagmentation-based analysis reveals the clonal behavior of CAR-T cells in association with lentivector integration sites;Molecular Therapy - Oncolytics;2023-09

2. Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructs;Molecular Therapy - Methods & Clinical Development;2023-06

3. Ex vivo factor VIII‐modified proliferating human hepatocytes therapy for haemophilia A;Cell Proliferation;2023-05

4. Characterizing piggyBat—a transposase for genetic modification of T cells;Molecular Therapy - Methods & Clinical Development;2022-06

5. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial;Nature Medicine;2022-03-21